243 related articles for article (PubMed ID: 22280219)
1. Quantitative analysis of multisite protein-ligand interactions by NMR: binding of intrinsically disordered p53 transactivation subdomains with the TAZ2 domain of CBP.
Arai M; Ferreon JC; Wright PE
J Am Chem Soc; 2012 Feb; 134(8):3792-803. PubMed ID: 22280219
[TBL] [Abstract][Full Text] [Related]
2. Mapping the interactions of the p53 transactivation domain with the KIX domain of CBP.
Lee CW; Arai M; Martinez-Yamout MA; Dyson HJ; Wright PE
Biochemistry; 2009 Mar; 48(10):2115-24. PubMed ID: 19220000
[TBL] [Abstract][Full Text] [Related]
3. Recognition of the disordered p53 transactivation domain by the transcriptional adapter zinc finger domains of CREB-binding protein.
Krois AS; Ferreon JC; Martinez-Yamout MA; Dyson HJ; Wright PE
Proc Natl Acad Sci U S A; 2016 Mar; 113(13):E1853-62. PubMed ID: 26976603
[TBL] [Abstract][Full Text] [Related]
4. Structural insights into TAZ2 domain-mediated CBP/p300 recruitment by transactivation domain 1 of the lymphopoietic transcription factor E2A.
Lochhead MR; Brown AD; Kirlin AC; Chitayat S; Munro K; Findlay JE; Baillie GS; LeBrun DP; Langelaan DN; Smith SP
J Biol Chem; 2020 Mar; 295(13):4303-4315. PubMed ID: 32098872
[TBL] [Abstract][Full Text] [Related]
5. Cooperative regulation of p53 by modulation of ternary complex formation with CBP/p300 and HDM2.
Ferreon JC; Lee CW; Arai M; Martinez-Yamout MA; Dyson HJ; Wright PE
Proc Natl Acad Sci U S A; 2009 Apr; 106(16):6591-6. PubMed ID: 19357310
[TBL] [Abstract][Full Text] [Related]
6. Structure of the p53 transactivation domain in complex with the nuclear receptor coactivator binding domain of CREB binding protein.
Lee CW; Martinez-Yamout MA; Dyson HJ; Wright PE
Biochemistry; 2010 Nov; 49(46):9964-71. PubMed ID: 20961098
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for p300 Taz2-p53 TAD1 binding and modulation by phosphorylation.
Feng H; Jenkins LM; Durell SR; Hayashi R; Mazur SJ; Cherry S; Tropea JE; Miller M; Wlodawer A; Appella E; Bai Y
Structure; 2009 Feb; 17(2):202-10. PubMed ID: 19217391
[TBL] [Abstract][Full Text] [Related]
8. Solution structure of the TAZ2 (CH3) domain of the transcriptional adaptor protein CBP.
De Guzman RN; Liu HY; Martinez-Yamout M; Dyson HJ; Wright PE
J Mol Biol; 2000 Oct; 303(2):243-53. PubMed ID: 11023789
[TBL] [Abstract][Full Text] [Related]
9. Two distinct motifs within the p53 transactivation domain bind to the Taz2 domain of p300 and are differentially affected by phosphorylation.
Jenkins LM; Yamaguchi H; Hayashi R; Cherry S; Tropea JE; Miller M; Wlodawer A; Appella E; Mazur SJ
Biochemistry; 2009 Feb; 48(6):1244-55. PubMed ID: 19166313
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the High-Affinity Fuzzy Complex between the Disordered Domain of the E7 Oncoprotein from High-Risk HPV and the TAZ2 Domain of CBP.
Risør MW; Jansma AL; Medici N; Thomas B; Dyson HJ; Wright PE
Biochemistry; 2021 Dec; 60(51):3887-3898. PubMed ID: 34905914
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation Regulates the Bound Structure of an Intrinsically Disordered Protein: The p53-TAZ2 Case.
Ithuralde RE; Turjanski AG
PLoS One; 2016; 11(1):e0144284. PubMed ID: 26742101
[TBL] [Abstract][Full Text] [Related]
12. Mapping the interactions of adenoviral E1A proteins with the p160 nuclear receptor coactivator binding domain of CBP.
Haberz P; Arai M; Martinez-Yamout MA; Dyson HJ; Wright PE
Protein Sci; 2016 Dec; 25(12):2256-2267. PubMed ID: 27699893
[TBL] [Abstract][Full Text] [Related]
13. Role of Intrinsic Protein Disorder in the Function and Interactions of the Transcriptional Coactivators CREB-binding Protein (CBP) and p300.
Dyson HJ; Wright PE
J Biol Chem; 2016 Mar; 291(13):6714-22. PubMed ID: 26851278
[TBL] [Abstract][Full Text] [Related]
14. Long-range regulation of p53 DNA binding by its intrinsically disordered N-terminal transactivation domain.
Krois AS; Dyson HJ; Wright PE
Proc Natl Acad Sci U S A; 2018 Nov; 115(48):E11302-E11310. PubMed ID: 30420502
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of glucocorticoid receptor tau1c transactivation domain enhances binding to CREB binding protein (CBP) TAZ2.
Carruthers CW; Suh JH; Gustafsson JA; Webb P
Biochem Biophys Res Commun; 2015 Jan; 457(1):119-23. PubMed ID: 25511704
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the p300 Taz2-p53 TAD2 complex and comparison with the p300 Taz2-p53 TAD1 complex.
Miller Jenkins LM; Feng H; Durell SR; Tagad HD; Mazur SJ; Tropea JE; Bai Y; Appella E
Biochemistry; 2015 Mar; 54(11):2001-10. PubMed ID: 25753752
[TBL] [Abstract][Full Text] [Related]
17. The high-risk HPV16 E7 oncoprotein mediates interaction between the transcriptional coactivator CBP and the retinoblastoma protein pRb.
Jansma AL; Martinez-Yamout MA; Liao R; Sun P; Dyson HJ; Wright PE
J Mol Biol; 2014 Dec; 426(24):4030-4048. PubMed ID: 25451029
[TBL] [Abstract][Full Text] [Related]
18. A phosphorylation-dependent switch in the disordered p53 transactivation domain regulates DNA binding.
Sun X; Dyson HJ; Wright PE
Proc Natl Acad Sci U S A; 2021 Jan; 118(1):. PubMed ID: 33443163
[TBL] [Abstract][Full Text] [Related]
19. Four domains of p300 each bind tightly to a sequence spanning both transactivation subdomains of p53.
Teufel DP; Freund SM; Bycroft M; Fersht AR
Proc Natl Acad Sci U S A; 2007 Apr; 104(17):7009-14. PubMed ID: 17438265
[TBL] [Abstract][Full Text] [Related]
20. Structure of tumor suppressor p53 and its intrinsically disordered N-terminal transactivation domain.
Wells M; Tidow H; Rutherford TJ; Markwick P; Jensen MR; Mylonas E; Svergun DI; Blackledge M; Fersht AR
Proc Natl Acad Sci U S A; 2008 Apr; 105(15):5762-7. PubMed ID: 18391200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
